Innovative technology can benefit ophthalmology practices

Ophthalmologists can improve surgical outcomes by incorporating new drugs and devices into their practices, according to a presentation at Real World Ophthalmology.
Mitchell A. Jackson, MD, said three innovations — Omidria (phenylephrine 1% and ketorolac 0.3% intraocular solution, Omeros/Rayner), Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) and Zepto (Centricity Vision) — have helped him do just that.
Omidria is indicated for maintaining pupil size by preventing intraoperative miosis, as well as reducing postoperative ocular pain.
“We know what happens

Full Story →